Company intelligence / Profile preview

Leman Biotech

Shenzhen, Guangdong, Chinalemanbio.com ↗

Ownership: Private
Employees: ~50
Development stage: Phase 1

Overview

The company’s lead program, Meta10‑19 metabolically armed CD19 CAR‑T therapy, has entered investigator‑initiated clinical trials for relapsed/refractory indolent B-cell non-Hodgkin lymphoma and recurrent/refractory lymphoma. Early results suggest promise at low doses. Their IL‑10/Fc fusion protein has shown up to a ~90% cure rate in preclinical studies.

No active industry-sponsored trials are currently listed on ClinicalTrials.gov as of May 2025.

Therapeutic areas: Oncology
Modalities: Cell therapies (CAR-T)Protein drugs (e.g., IL-10/Fc fusion protein)Metabolic immunotherapies
Industry: Biotech

Drug pipeline

9 assets

metabolically armed tumor-infiltrating lymphocytes

8 more assets in the full pipeline.

Partnerships

XtalPi (AI-driven drug R&D partner/co-founder)First Affiliated Hospital of Zhejiang University School of Medicine (clinical trial site/partner)

Beyond the preview

Go deeper on Leman Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leman Biotech.